LY2940094

· BlackThorn Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY2940094, covering 2017-02-03 to 2017-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2940094 in Participants With Alcohol Dependency [Phase 2]